Cardio Diagnostics Holdings, Inc. develops and commercializes epigenetics-based clinical tests for cardiovascular disease. It offers Epi+Gen CHD, a three-year symptomatic coronary heart disease risk assessment test. Cardio Diagnostics Holdings, Inc. was founded in 2017 and is based in Chicago, Illinois.
The current price of CDIO is $2.09 USD — it has increased by +7.18% in the past 24 hours. Watch Cardio Diagnostics stock price performance more closely on the chart.
What is Cardio Diagnostics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Cardio Diagnostics stocks are traded under the ticker CDIO.
Is Cardio Diagnostics stock price growing?▼
CDIO stock has fallen by -1.45% compared to the previous week, the month change is a -68.85% fall, over the last year Cardio Diagnostics has showed a -81.11% decrease.
What is Cardio Diagnostics market cap?▼
Today Cardio Diagnostics has the market capitalization of 3.82M
When is the next Cardio Diagnostics earnings date?▼
Cardio Diagnostics is going to release the next earnings report on June 03, 2026.
What were Cardio Diagnostics earnings last quarter?▼
CDIO earnings for the last quarter are -0.8 USD per share, whereas the estimation was N/A USD resulting in a N/A surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Cardio Diagnostics revenue for the last year?▼
Cardio Diagnostics revenue for the last year amounts to 70,000 USD.
What is Cardio Diagnostics net income for the last year?▼
CDIO net income for the last year is -16.77M USD.
How many employees does Cardio Diagnostics have?▼
As of April 01, 2026, the company has 13 employees.
In which sector is Cardio Diagnostics located?▼
Cardio Diagnostics operates in the Health Care sector.
When did Cardio Diagnostics complete a stock split?▼
The last stock split for Cardio Diagnostics was on May 13, 2025 with a ratio of 1:30.
Where is Cardio Diagnostics headquartered?▼
Cardio Diagnostics is headquartered in Chicago, US.